Asset Allocation

As of November 30, 2025.
Type % Net
Cash 2.35%
Stock 95.73%
Bond 1.88%
Convertible 0.00%
Preferred 0.00%
Other 0.03%
View Asset Allocation
Start Trial

Market Capitalization

As of November 30, 2025
Large 83.85%
Mid 11.64%
Small 4.51%
View Market Capitalization
Start Trial

Region Exposure

% Developed Markets: 97.61%    % Emerging Markets: 0.00%    % Unidentified Markets: 2.39%

Americas 77.80%
77.80%
Canada 6.92%
United States 70.88%
0.00%
As of November 30, 2025. Region breakdown data is calculated by using the long position holdings of the portfolio.
Greater Europe 19.81%
United Kingdom 2.84%
14.26%
France 1.48%
Ireland 3.50%
Netherlands 3.76%
Switzerland 5.52%
0.00%
2.71%
Israel 2.71%
Greater Asia 0.00%
Japan 0.00%
0.00%
0.00%
0.00%
Unidentified Region 2.39%

Stock Sector Exposure

Cyclical
31.02%
Materials
5.81%
Consumer Discretionary
6.37%
Financials
16.00%
Real Estate
2.84%
Sensitive
47.61%
Communication Services
11.80%
Energy
0.00%
Industrials
8.46%
Information Technology
27.36%
Defensive
17.15%
Consumer Staples
4.21%
Health Care
12.94%
Utilities
0.00%
Not Classified
4.22%
Non Classified Equity
0.00%
Not Classified - Non Equity
4.22%
As of November 30, 2025
View Region Exposure
Start Trial

Stock Style Exposure

Large Cap Value --
Large Cap Core --
Large Cap Growth --
Mid Cap Value --
Mid Cap Core --
Mid Cap Growth --
Small Cap Value --
Small Cap Core --
Small Cap Growth --
No Data Available